Ambu blames hospital staff shortage for European setback
The medtech company’s negative growth in Europe is being worked on, emphasizes the company’s CEO, Britt Meelby Jensen.
by ulrich quistgaard, translated by daniel pedersen
European growth hasn’t merely stopped in its tracks for medtech company Ambu – it’s actually reversed into the negative, sliding from 7% organic growth to negative 1% between quarters year-over-year, the most recent financial report revealed.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
